Growing prevalence of chronic diseases such as cancer and diabetes and increasing number of new drug discovery & development activities are some of the key factors driving market revenue growth.
Growing prevalence of chronic diseases such as cancer and diabetes and increasing number of new drug discovery & development activities are some of the key factors driving market revenue growth
According to Emergen Research, the global RNA transcriptomics market size was USD 4.46 billion in 2020 and is expected to reach USD 12.46 billion in 2028 and register a revenue CAGR of 13.6% during the forecast period, 2021-2028.
Market Dynamics:
Rapid revenue growth of the global RNA transcriptomics market is driven by factors such as rising burden of chronic diseases such as cancer and diabetes across the globe, growing geriatric population, rising prevalence of genetic disorders, and rising focus on study of gene mutations in cancer genes and genetic variations. Other major factors contributing to revenue growth of this market over the forecast period increasing demand for precision medicine, rising number of clinical research activities and new drug discovery & development projects, increasing applications of RNA transcriptomics in gene expression studies, growing demand for advanced clinical biomarkers, growing need for improved analysis of gene-to-drug interactions, and increasing public and private investments in R&D activities in the pharmaceutical and biotechnology sectors.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/610
RNA transcriptomics refers to the in-depth study and analysis of RNA transcriptomes that are present in individual cells, using a number of high-throughput techniques. RNA transcriptomics is a vital part of gene expression studies and examines all the key elements of mRNA, microRNA, and non-coding RNA transcripts. The technique helps identify and analyze the transcriptional structure of genes, and it closely assesses the changing nature of RNA transcripts at different stages of development. RNA interference, RNA sequencing, real-time polymerase chain reaction (RT-PCR), expressed sequence tag (EST)-based methods, and microarrays are some of the different techniques used in RNA transcriptomics.
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Reagents Segment Accounted for Largest Revenue Share in 2020:
The reagents segment dominated other segments in terms of revenue share in the global market in 2020. Major factors driving revenue growth of this segment are rising prevalence of chronic and genetic disorders, increasing applications of RNA transcriptomics in gene expression studies, and increasing applications of high-performance reagents in real-time polymerase chain reaction (RT-PCR), RNA sequencing, and microarrays.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/610
Drug Discovery & Development Segment to Account for Fastest Revenue CAGR:
The drug discovery & development segment is expected to register the fastest revenue growth rate in the global market over the forecast period. Increasing applications of RNA transcriptomics in novel drug discovery & development projects, growing demand for precision medicine, and rise in R&D activities in the areas of genomics and proteomics are key factors expected to contribute to this segment’s revenue growth.
North America Market Accounted for Largest Revenue Share in 2020:
Among regional markets, the North America RNA transcriptomics market accounted for the largest revenue share in the global market in 2020. Major factors providing impetus to the North America market revenue growth are increasing prevalence of cancer, diabetes, and various genetic diseases, rise in R&D activities in the fields of genomics and proteomics, increasing focus on new drug development, increasing public and private investments in the pharmaceutical and biotechnology sectors, and presence of leading market players in the region, including Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, and Illumina, Inc.
Major Companies in the Global RNA Transcriptomics Market Include:
- Thermo Fisher Scientific
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Agilent Technologies, Inc.
- Illumina, Inc.
- GenXPro GmbH
- Fluidigm Corporation
- CD Genomics
- Sequentia Biotech SL
- Acobiom
- Others
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/rna-transcriptomics-market
For the purpose of this report, Emergen Research has segmented the global RNA transcriptomics market based on product type, technology, application, end-use, and region:
Product Type Outlook (Revenue: USD Billion; 2018–2028)
- Reagents
- Instruments
- Software
- Service
Technology Outlook (Revenue: USD Billion; 2018–2028)
- Microarrays
- Polymerase Chain Reaction
- RNA Sequencing
- RNA Interference
Application Outlook (Revenue: USD Billion; 2018–2028)
- Clinical Diagnostics
- Toxicogenomics
- Drug Discovery & Development
- Comparative Transcriptomics
End-use Outlook (Revenue: USD Billion; 2018–2028)
- Hospitals
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations (CROs)
Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/610
Region Outlook (Revenue, USD Billion; 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of Middle East & Africa
Related Published Articles Published by Emergen Research:
Metastatic Cancer Treatment Market
Thermoelectric Materials Market
Unmanned Composite Materials Market
Commercial Vehicle Sensors Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/press-release/global-rna-transcriptomics-market